Jazz Pharmaceuticals: Epilepsy trials
The registry lists 11 Epilepsy studies with Jazz Pharmaceuticals as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 1Phase 2 6Phase 3 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic SeizuresTerminatedNCT05288283Phase 3Results posted
- Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled SeizuresTerminatedNCT04485104Phase 3Results posted
- CX-8998 for Absence SeizuresCompletedNCT03406702Phase 2Results posted
- A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02565108Phase 2Results posted
- An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02564952Phase 2Results posted
- GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet SyndromeCompletedNCT02224703Phase 3Results posted
- A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsCompletedNCT02224690Phase 3Results posted
- Study of Intranasal Clonazepam in Adult Subjects With Epileptic SeizuresCompletedNCT00594945Phase 2Results posted
- An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With EpilepsyCompletedNCT02607904Phase 2
- A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With EpilepsyCompletedNCT02607891Phase 2
- A Study of the Safety and Tolerability of GWP42006 in Healthy SubjectsCompletedNCT01918735Phase 1